Target intelligence / Profile preview

Novel transcript, sense intronic to CDK13 (ENSG00000289269)

Target: ENSG00000289269
Molecular classification: Other (Sense intronic non-coding transcript)

Overview

This entity is a novel, non-coding transcript located within an intron of the CDK13 gene (cyclin-dependent kinase 13), transcribed in the same (sense) direction as CDK13. It is uncharacterized, with unknown function, no annotated protein product, and no evidence for involvement in disease or as a therapeutic target.

Other names: ENSG00000289269

Beyond the preview

Go deeper on Novel transcript, sense intronic to CDK13 (ENSG00000289269).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to CDK13 (ENSG00000289269).

Explore the full profile